Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histone H1.3 is a member of the linker histone H1 family, which are basic nuclear proteins required for the packaging of DNA into chromatin in eukaryotic cells. Unlike core histones, H1.3 binds to linker DNA between nucleosomes, thereby facilitating the condensation of chromatin into higher-order structures and playing an essential role in genome organization and gene regulation. H1.3 also participates in nucleosome spacing, chromatin fiber formation, and modulation of gene transcription through chromatin remodeling and potential interactions with chromatin-associated proteins. It is one of several H1 variants, and is expressed in a replication-dependent manner during S-phase of the cell cycle. No clinically approved drugs are known to target Histone H1.3, and it is not typically considered a direct pharmacological target. However, its function is critical for normal chromatin dynamics, cell viability, and epigenetic regulation.
Not applicable. No drugs currently target this molecule directly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histone H1.3 (H1-3).